Literature DB >> 12773428

Carrageenan formulation prevents macrophage trafficking from vagina: implications for microbicide development.

Maria-Elisa Perotti1, Alessia Pirovano, David M Phillips.   

Abstract

Considerable evidence suggests that human immunodeficiency virus (HIV)-infected macrophages and/or lymphocytes may mediate sexual transmission of HIV. We and others have previously demonstrated that when vitally stained donor mouse lymphocytes or macrophages are placed in the vaginas of mice, some of the stained cells can later be found in the iliac lymph nodes. The aim of this study was to assess the extent of mononuclear cell trafficking from the vagina and to test the possibility that carrageenan formulation, a sulfated polysaccharide formulation containing 3% PDR98-15 carrageenan (PC-515; FMC Biopolymer, Rockland, ME), a vaginal microbicide, would prevent vaginal transmigration of macrophages. When supravitally stained mouse macrophages and T cells were inoculated into the vagina of recipient mice, discrete numbers of donor cells migrated to the recipient iliac and inguinal lymph nodes and spleen. When recipient mice were preinoculated with the carrageenan formulation, the number of macrophages in lymph nodes and spleen was reduced by >90%. In contrast, a methylcellulose formulation, which is believed to be inactive, did not significantly reduce migration to the lymphoid organs. Our findings suggest that the carrageenan formulation blocks cell trafficking of macrophages from vagina and that blocking does not result from cytotoxicity. Blocking cell trafficking may help to prevent sexual transmission of HIV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773428     DOI: 10.1095/biolreprod.102.014555

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  13 in total

Review 1.  Novel targets for antiretroviral therapy: clinical progress to date.

Authors:  Birgitt Dau; Mark Holodniy
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 2.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

3.  Combinations of 3-hydroxyphthalic anhydride-modified ovalbumin with antiretroviral drug-based microbicide candidates display synergistic and complementary effects against HIV-1 infection.

Authors:  Lin Li; Suiyi Tan; Hong Lu; Lu Lu; Jie Yang; Hong Jin; Shuwen Liu; Shibo Jiang
Journal:  J Acquir Immune Defic Syndr       Date:  2011-04-15       Impact factor: 3.731

4.  3-hydroxyphthalic anhydride-modified chicken ovalbumin exhibits potent and broad anti-HIV-1 activity: a potential microbicide for preventing sexual transmission of HIV-1.

Authors:  Lin Li; Lili He; Suiyi Tan; Xinhua Guo; Hong Lu; Zhi Qi; Chungen Pan; Xiuli An; Shibo Jiang; Shuwen Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-03-01       Impact factor: 5.191

Review 5.  Vaginal microbicides and the prevention of HIV transmission.

Authors:  Blayne Cutler; Jessica Justman
Journal:  Lancet Infect Dis       Date:  2008-11       Impact factor: 25.071

6.  Maleic anhydride-modified chicken ovalbumin as an effective and inexpensive anti-HIV microbicide candidate for prevention of HIV sexual transmission.

Authors:  Lin Li; Pengyuan Qiao; Jie Yang; Lu Lu; Suiyi Tan; Hong Lu; Xiujuan Zhang; Xi Chen; Shuguang Wu; Shibo Jiang; Shuwen Liu
Journal:  Retrovirology       Date:  2010-04-26       Impact factor: 4.602

Review 7.  A review of current intravaginal drug delivery approaches employed for the prophylaxis of HIV/AIDS and prevention of sexually transmitted infections.

Authors:  Valence M K Ndesendo; Viness Pillay; Yahya E Choonara; Eckhart Buchmann; David N Bayever; Leith C R Meyer
Journal:  AAPS PharmSciTech       Date:  2008-04-02       Impact factor: 3.246

8.  Evaluation of microporous polycaprolactone matrices for controlled delivery of antiviral microbicides to the female genital tract.

Authors:  Naghme Hajarol Asvadi; Nhung T T Dang; Nicholas Davis-Poynter; Allan G A Coombes
Journal:  J Mater Sci Mater Med       Date:  2013-07-28       Impact factor: 3.896

Review 9.  Microbicides: a new hope for HIV prevention.

Authors:  Satish K Gupta
Journal:  Indian J Med Res       Date:  2011-12       Impact factor: 2.375

Review 10.  Blocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responses.

Authors:  Sahar G Eid; Niamh E Mangan; Paul J Hertzog; Johnson Mak
Journal:  Clin Transl Immunology       Date:  2015-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.